Edwards Lifesciences CorporationEWNYSE
Loading
Asset Growth TrendStable
Percentile Rank41
5Y CAGR-13.0%
Year-over-Year Change
Year-over-year total asset growth rate
5Y CAGR
-13.0%/yr
Long-term compound
Percentile
P41
Within normal range
vs 5Y Ago
0.5x
Contraction
Streak
1 qtr
Consecutive growthStable
| Period | Value |
|---|---|
| Q4 2025 | 3.20% |
| Q3 2025 | -1.61% |
| Q2 2025 | 3.58% |
| Q1 2025 | -0.25% |
| Q4 2024 | 0.65% |
| Q3 2024 | 28.44% |
| Q2 2024 | 3.73% |
| Q1 2024 | 3.98% |
| Q4 2023 | -0.08% |
| Q3 2023 | 4.07% |
| Q2 2023 | 4.08% |
| Q1 2023 | 4.33% |
| Q4 2022 | -4.00% |
| Q3 2022 | 2.53% |
| Q2 2022 | 0.06% |
| Q1 2022 | -0.97% |
| Q4 2021 | 4.19% |
| Q3 2021 | 6.50% |
| Q2 2021 | 6.22% |
| Q1 2021 | -0.32% |
| Q4 2020 | 6.42% |
| Q3 2020 | 5.86% |
| Q2 2020 | 5.73% |
| Q1 2020 | -6.35% |
| Q4 2019 | 8.75% |
| Q3 2019 | 7.05% |
| Q2 2019 | 1.91% |
| Q1 2019 | 2.73% |
| Q4 2018 | -10.65% |
| Q3 2018 | 4.79% |
| Q2 2018 | -2.39% |
| Q1 2018 | 2.26% |
| Q4 2017 | 3.79% |
| Q3 2017 | 6.81% |
| Q2 2017 | 7.49% |
| Q1 2017 | 6.00% |
| Q4 2016 | 3.94% |
| Q3 2016 | 7.10% |
| Q2 2016 | 5.13% |
| Q1 2016 | -5.06% |